Oral Ibuprofen Interferes with Cellular Healing Responses in a Murine Model of Achilles Tendinopathy.

Adam Bittermann, Shuguang Gao, Sabah Rezvani, Jun Li, Katie J Sikes, John Sandy, Vincent Wang, Simon Lee, George Holmes, Johnny Lin, Anna Plaas
{"title":"Oral Ibuprofen Interferes with Cellular Healing Responses in a Murine Model of Achilles Tendinopathy.","authors":"Adam Bittermann,&nbsp;Shuguang Gao,&nbsp;Sabah Rezvani,&nbsp;Jun Li,&nbsp;Katie J Sikes,&nbsp;John Sandy,&nbsp;Vincent Wang,&nbsp;Simon Lee,&nbsp;George Holmes,&nbsp;Johnny Lin,&nbsp;Anna Plaas","doi":"10.23937/2572-3243.1510049","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The attempted healing of tendon after acute injury (overloading, partial tear or complete rupture) proceeds via the normal wound healing cascade involving hemostasis, inflammation, matrix synthesis and matrix remodeling. Depending on the degree of trauma and the nature of the post-injury milieu, a variable degree of healing and recovery of function occurs. Post-injury analgesia is often achieved with NSAIDs such as Ibuprofen, however there is increasing evidence that NSAID usage may interfere with the healing process. This study aimed to investigate the cellular mechanism by which IBU therapy might lead to a worsening of tendon pathology.</p><p><strong>Methods: </strong>We have examined the effect of oral Ibuprofen, on Achilles tendon healing in a TGFb1-induced murine tendinopathy model. Dosing was started 3 days after initial injury (acute cellular response phase) and continued for 22 days or started at 9 days after injury (transition to matrix regeneration phase) and given for 16 days. Cellular changes in tendon and surrounding peritenon were assessed using Hematoxylin/Eosin, chondroid accumulation with Safranin O and anti-aggrecan immunohistochemistry, and neo-vessel formation with GSI Lectin histochemistry. Markers of inflammation included histochemical localization of hyaluronan, immunohistochemistry of heavy chain 1 and TNFα-stimulated glycoprotein-6 (TSG6). Cell responses were further examined by RT-qPCR of 84 NFκB target genes and 84 wound healing genes. Biomechanical properties of tendons were evaluated by tensile testing.</p><p><strong>Results: </strong>At a clinically-relevant dosage, Ibuprofen prevented the process of remodeling/removal of the inflammatory matrix components, hyaluronan, HC1 and TSG6. Furthermore, the aberrant matrix remodeling was accompanied by activation at day 28 of genes (<i>Col1a2, Col5a3, Plat, Ccl12, Itga4, Stat3, Vegfa, Mif, Col4a1, Rhoa, Relb, F8, Cxcl9, Lta, Ltb, Ccl12, Cdkn1a, Ccl22, Sele, Cd80</i>), which were not activated at any time without the drug, and so appear most likely to be involved in the pathology. Of these, <i>Vegfa, Col4a1, F8, Cxcl9</i> and <i>Sele</i>, have been shown to play a role in vascular remodeling, consistent with the appearance at 25 days of vasculogenic cell groups in the peritenon and fat pad stroma surrounding the Achilles of the drug-dosed mice. Tensile stiffness (p = 0.004) and elastic modulus (p = 0.012) were both decreased (relative to age-matched uninjured and non-dosed mice) in mice dosed with Ibuprofen from day 3 to day 25, whether injured or not.</p><p><strong>Conclusion: </strong>We conclude that the use of Ibuprofen for pain relief during inflammatory phases of tendinopathy, might interfere with the normal processes of extracellular matrix remodeling and cellular control of expression of inflammatory and wound healing genes. It is proposed that the known COX2-mediated anti-inflammatory effect of ibuprofen has detrimental effects on the turnover of a pro-inflammatory HA matrix produced in response to soft-tissue injury, thus preventing the switch to cellular responses associated with functional matrix remodeling and eventual healing.</p>","PeriodicalId":16374,"journal":{"name":"Journal of musculoskeletal disorders and treatment","volume":"4 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.23937/2572-3243.1510049","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of musculoskeletal disorders and treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2572-3243.1510049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/5/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Background: The attempted healing of tendon after acute injury (overloading, partial tear or complete rupture) proceeds via the normal wound healing cascade involving hemostasis, inflammation, matrix synthesis and matrix remodeling. Depending on the degree of trauma and the nature of the post-injury milieu, a variable degree of healing and recovery of function occurs. Post-injury analgesia is often achieved with NSAIDs such as Ibuprofen, however there is increasing evidence that NSAID usage may interfere with the healing process. This study aimed to investigate the cellular mechanism by which IBU therapy might lead to a worsening of tendon pathology.

Methods: We have examined the effect of oral Ibuprofen, on Achilles tendon healing in a TGFb1-induced murine tendinopathy model. Dosing was started 3 days after initial injury (acute cellular response phase) and continued for 22 days or started at 9 days after injury (transition to matrix regeneration phase) and given for 16 days. Cellular changes in tendon and surrounding peritenon were assessed using Hematoxylin/Eosin, chondroid accumulation with Safranin O and anti-aggrecan immunohistochemistry, and neo-vessel formation with GSI Lectin histochemistry. Markers of inflammation included histochemical localization of hyaluronan, immunohistochemistry of heavy chain 1 and TNFα-stimulated glycoprotein-6 (TSG6). Cell responses were further examined by RT-qPCR of 84 NFκB target genes and 84 wound healing genes. Biomechanical properties of tendons were evaluated by tensile testing.

Results: At a clinically-relevant dosage, Ibuprofen prevented the process of remodeling/removal of the inflammatory matrix components, hyaluronan, HC1 and TSG6. Furthermore, the aberrant matrix remodeling was accompanied by activation at day 28 of genes (Col1a2, Col5a3, Plat, Ccl12, Itga4, Stat3, Vegfa, Mif, Col4a1, Rhoa, Relb, F8, Cxcl9, Lta, Ltb, Ccl12, Cdkn1a, Ccl22, Sele, Cd80), which were not activated at any time without the drug, and so appear most likely to be involved in the pathology. Of these, Vegfa, Col4a1, F8, Cxcl9 and Sele, have been shown to play a role in vascular remodeling, consistent with the appearance at 25 days of vasculogenic cell groups in the peritenon and fat pad stroma surrounding the Achilles of the drug-dosed mice. Tensile stiffness (p = 0.004) and elastic modulus (p = 0.012) were both decreased (relative to age-matched uninjured and non-dosed mice) in mice dosed with Ibuprofen from day 3 to day 25, whether injured or not.

Conclusion: We conclude that the use of Ibuprofen for pain relief during inflammatory phases of tendinopathy, might interfere with the normal processes of extracellular matrix remodeling and cellular control of expression of inflammatory and wound healing genes. It is proposed that the known COX2-mediated anti-inflammatory effect of ibuprofen has detrimental effects on the turnover of a pro-inflammatory HA matrix produced in response to soft-tissue injury, thus preventing the switch to cellular responses associated with functional matrix remodeling and eventual healing.

Abstract Image

Abstract Image

Abstract Image

口服布洛芬干扰小鼠跟腱病模型的细胞愈合反应。
背景:急性损伤(超载、部分撕裂或完全断裂)后肌腱的愈合是通过正常的伤口愈合级联进行的,包括止血、炎症、基质合成和基质重塑。根据创伤程度和损伤后环境的性质,发生不同程度的愈合和功能恢复。损伤后镇痛通常用非甾体抗炎药如布洛芬来实现,然而越来越多的证据表明非甾体抗炎药的使用可能会干扰愈合过程。本研究旨在探讨IBU治疗可能导致肌腱病理恶化的细胞机制。方法:研究口服布洛芬对tgfb1诱导的小鼠跟腱病模型跟腱愈合的影响。在初始损伤后3天(急性细胞反应期)开始给药,持续22天或在损伤后9天(过渡到基质再生期)开始给药,持续16天。采用苏木精/伊红染色评估肌腱和周围腹膜的细胞变化,用红素O和抗聚集蛋白免疫组化评估软骨样物质积聚,用GSI凝集素组织化学评估新血管形成。炎症标志物包括透明质酸的组织化学定位、重链1的免疫组织化学和tnf α刺激的糖蛋白-6 (TSG6)。通过RT-qPCR检测84个NFκB靶基因和84个创面愈合基因的细胞反应。通过拉伸试验评估肌腱的生物力学性能。结果:在临床相关剂量下,布洛芬可以阻止炎症基质成分、透明质酸、HC1和TSG6的重塑/去除过程。此外,异常基质重塑还伴随着28天基因(Col1a2, Col5a3, Plat, Ccl12, Itga4, Stat3, Vegfa, Mif, Col4a1, Rhoa, Relb, F8, Cxcl9, Lta, lbb, Ccl12, Cdkn1a, Ccl22, Sele, Cd80)的激活,这些基因在没有药物的情况下在任何时候都没有激活,因此最有可能参与病理。其中,Vegfa、Col4a1、F8、Cxcl9和Sele已被证明在血管重塑中发挥作用,这与用药小鼠跟腱周围的腹膜和脂肪垫基质中25天血管生成细胞群的出现一致。从第3天到第25天,无论是否受伤,布洛芬给药小鼠的拉伸刚度(p = 0.004)和弹性模量(p = 0.012)均降低(相对于年龄匹配的未受伤和未给药小鼠)。结论:在肌腱病变炎症期使用布洛芬缓解疼痛可能会干扰细胞外基质重塑和细胞对炎症和伤口愈合基因表达的控制。研究人员提出,已知的cox2介导的布洛芬抗炎作用对软组织损伤产生的促炎HA基质的转换有不利影响,从而阻止了与功能性基质重塑和最终愈合相关的细胞反应的转换。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信